BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10894963)

  • 1. Intralesional methotrexate as effective treatment in solitary giant keratoacanthoma of the lower lip.
    Spieth K; Gille J; Kaufmann R
    Dermatology; 2000; 200(4):317-9. PubMed ID: 10894963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intralesional infusion of methotrexate as neoadjuvant therapy improves the cosmetic and functional results of surgery to treat keratoacanthoma: results of a randomized trial].
    Martorell-Calatayud A; Requena C; Nagore E; Sanmartín O; Serra-Guillén C; Botella-Estrada R; Sanz-Motilva V; Llombart B; Alcañiz-Moscardo A; Guillén-Barona C
    Actas Dermosifiliogr; 2011 Oct; 102(8):605-15. PubMed ID: 21742301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of giant keratoacanthoma of the skin of the lower lip with intralesional methotrexate: a case report.
    de Visscher JG; van der Wal KG; Blanken R; Willemse F
    J Oral Maxillofac Surg; 2002 Jan; 60(1):93-5. PubMed ID: 11757016
    [No Abstract]   [Full Text] [Related]  

  • 4. Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective study and review of the literature.
    Annest NM; VanBeek MJ; Arpey CJ; Whitaker DC
    J Am Acad Dermatol; 2007 Jun; 56(6):989-93. PubMed ID: 17504715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eruptive Keratoacanthomas in a Red Tattoo.
    Linares-Gonzalez L; Ródenas-Herranz T; Galvez-Moreno M; Ruiz-Villaverde R
    Sultan Qaboos Univ Med J; 2020 Aug; 20(3):e372-e373. PubMed ID: 33110656
    [No Abstract]   [Full Text] [Related]  

  • 6. Intralesional methotrexate versus 5-flurouracil in the treatment of keratoacanthoma.
    Nofal A; Alakad R; Wahid R; Hoseiny HAM
    Arch Dermatol Res; 2024 Jun; 316(7):400. PubMed ID: 38878177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intralesional methotrexate as non-surgical therapy for giant keratoacanthoma on the nose.
    Sayan A; Taibjee S; Ilankovan V
    Br J Oral Maxillofac Surg; 2024 Feb; 62(2):203-205. PubMed ID: 38267280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An ultrastructural study of the keratoacanthoma treated with methotrexate and 5-fluorouracil.
    Prutkin L
    Dermatologica; 1968; 137(6):373-80. PubMed ID: 5725794
    [No Abstract]   [Full Text] [Related]  

  • 9. Solitary Large Keratoacanthomas of the Head and Neck: An Observational Study.
    Rossi AM; Park B; Qi B; Lee EH; Busam KJ; Nehal KS
    Dermatol Surg; 2017 Jun; 43(6):810-816. PubMed ID: 28296794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of keratoacanthomas with intralesional methotrexate.
    Melton JL; Nelson BR; Stough DB; Brown MD; Swanson NA; Johnson TM
    J Am Acad Dermatol; 1991 Dec; 25(6 Pt 1):1017-23. PubMed ID: 1810980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keratoacanthoma arising in nevus comedonicus.
    Zarkik S; Bouhllab J; Methqal A; Afifi Y; Senouci K; Hassam B
    Dermatol Online J; 2012 Jul; 18(7):4. PubMed ID: 22863626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective case series.
    Aubut N; Alain J; Claveau J
    J Cutan Med Surg; 2012; 16(3):212-7. PubMed ID: 22713449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Solitary Keratoacanthoma of the Nose With Intralesional Methotrexate and Review of the Literature.
    Doerfler L; Hanke CW
    J Drugs Dermatol; 2019 Jul; 18(7):693-696. PubMed ID: 31334929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Check Program.
    Dixon A
    Aust Fam Physician; 2007 Aug; 36(8):583; discussion 583-4. PubMed ID: 17715562
    [No Abstract]   [Full Text] [Related]  

  • 15. Differentiating Keratoacanthoma From Squamous Cell Carcinoma: Are We Losing the Battle or Our Bearings? - Comment on "Intralesional Methotrexate for Keratoacanthomas: A Case Series".
    López Sanz P; Fernández-Parrado M; Escario Travesedo E
    Actas Dermosifiliogr; 2024 Mar; 115(3):328-329. PubMed ID: 37716500
    [No Abstract]   [Full Text] [Related]  

  • 16. Eruptive keratoacanthomas as a complication of fractionated CO2 laser resurfacing and combination therapy with imiquimod and intralesional methotrexate.
    Panther D; Nino T; Macknet KD; Macknet C
    Dermatol Surg; 2015 Jan; 41(1):172-5. PubMed ID: 25533164
    [No Abstract]   [Full Text] [Related]  

  • 17. Multiple familial keratoacanthoma of Witten and Zak - A report of three siblings.
    Agarwal M; Chander R; Karmakar S; Walia R
    Dermatology; 1999; 198(4):396-9. PubMed ID: 10449942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of multiple keratoacanthoma centrifugum marginatum.
    Mangas C; Bielsa I; Ribera M; Fernández-Figueras MT; Ferrándiz C
    Dermatol Surg; 2004 May; 30(5):803-6. PubMed ID: 15099330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance of Nonmelanoma Skin Cancer to Nonsurgical Treatments. Part II: Photodynamic Therapy, Vismodegib, Cetuximab, Intralesional Methotrexate, and Radiotherapy.
    Gracia-Cazaña T; Salazar N; Zamarrón A; Mascaraque M; Lucena SR; Juarranz Á
    Actas Dermosifiliogr; 2016 Nov; 107(9):740-750. PubMed ID: 27436804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of intralesional methotrexate in specific cutaneous involvement of B-cell chronic lymphocytic leukaemia.
    Anyfantakis V; Dammak A; Wierzbicka-Hainaut E; Camus M; Osdoit S; Levilain P; Guillet G
    J Eur Acad Dermatol Venereol; 2010 Jul; 24(7):856. PubMed ID: 19943835
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.